{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:43:28Z","timestamp":1784249008245,"version":"3.55.0"},"reference-count":80,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F30CA224986"],"award-info":[{"award-number":["F30CA224986"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["OC160076"],"award-info":[{"award-number":["OC160076"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>High-grade serous ovarian cancer is a deadly disease that can originate from the fallopian tube or the ovarian surface epithelium. The PAX (paired box) genes PAX2 and PAX8 are lineage-specific transcription factors required during development of the fallopian tube but not in the development of the ovary. PAX2 expression is lost early in serous cancer progression, while PAX8 is expressed ubiquitously. These proteins are implicated in migration, invasion, proliferation, cell survival, stem cell maintenance, and tumor growth. Hence, targeting PAX2 and PAX8 represents a promising drug strategy that could inhibit these pro-tumorigenic effects. In this review, we examine the implications of PAX2 and PAX8 expression in the cell of origin of serous cancer and their potential efficacy as drug targets by summarizing their role in the molecular pathogenesis of ovarian cancer.<\/jats:p>","DOI":"10.3390\/cancers10080262","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T03:33:48Z","timestamp":1533785628000},"page":"262","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer"],"prefix":"10.3390","volume":"10","author":[{"given":"Laura R.","family":"Hardy","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Salvi","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna E.","family":"Burdette","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1158\/1078-0432.CCR-15-0887","article-title":"FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy","volume":"21","author":"Kim","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.ogx.0000452705.82050.e4","article-title":"Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial","volume":"69","author":"Hilpert","year":"2014","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrc1778","article-title":"A PANorama of PAX genes in cancer and development","volume":"6","author":"Robson","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Eccles, M.R., and Li, C.G. (2012). PAX Genes in Cancer; Friends or Foes?. Front. Genet., 3.","DOI":"10.3389\/fgene.2012.00006"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0b013e3182025f66","article-title":"Expression of PAX8 in normal and neoplastic tissues: A comprehensive immunohistochemical study","volume":"19","author":"Tacha","year":"2011","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.3390\/ijms14036090","article-title":"PAX2 Expression in Ovarian Cancer","volume":"14","author":"Song","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/modpathol.2009.92","article-title":"PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas","volume":"22","author":"Tung","year":"2009","journal-title":"Mod. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/modpathol.3800827","article-title":"Expression of PAX2 in papillary serous carcinoma of the ovary: Immunohistochemical evidence of fallopian tube or secondary M\u00fcllerian system origin?","volume":"20","author":"Tong","year":"2007","journal-title":"Mod. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1530\/rep.0.1230743","article-title":"Roles of the ovarian surface epithelium in ovulation and carcinogenesis","volume":"123","author":"Murdoch","year":"2002","journal-title":"Reproduction"},{"key":"ref_18","first-page":"255","article-title":"Ovarian surface epithelium: Biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/1097-0142(19950715)76:2<284::AID-CNCR2820760219>3.0.CO;2-5","article-title":"A prospective study of reproductive factors and risk of epithelial ovarian cancer","volume":"76","author":"Hankinson","year":"1995","journal-title":"Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ijc.2910530207","article-title":"Long-term impact of reproductive factors on cancer risk","volume":"53","author":"Negri","year":"1993","journal-title":"Int. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fonc.2014.00053","article-title":"A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population","volume":"4","author":"McCloskey","year":"2014","journal-title":"Front. Oncol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nm1230","article-title":"Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract","volume":"11","author":"Cheng","year":"2005","journal-title":"Nat. Med."},{"key":"ref_24","first-page":"3459","article-title":"Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium","volume":"63","author":"Choi","year":"2003","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2013evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e80314-10","DOI":"10.1371\/journal.pone.0080314","article-title":"Gene Expression Signature of Normal Cell-of-Origin Predicts Ovarian Tumor Outcomes","volume":"8","author":"Merritt","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_28","first-page":"1616","article-title":"Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"Mass Med. Soc."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Falconer, H., Yin, L., Gr\u00f6nberg, H., and Altman, D. (2015). Ovarian cancer risk after salpingectomy: A nationwide population-based study. J. Natl. Cancer Inst., 107.","DOI":"10.1093\/jnci\/dju410"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"126295","DOI":"10.1155\/2010\/126295","article-title":"Precursor lesions of high-grade serous ovarian carcinoma: Morphological and molecular characteristics","volume":"2010","author":"Gross","year":"2010","journal-title":"J. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_33","first-page":"7","article-title":"PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation","volume":"67","author":"Russo","year":"2018","journal-title":"Oncogene"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"20500","DOI":"10.18632\/oncotarget.3985","article-title":"Tumorigenesis and peritoneal colonization from fallopian tube epithelium","volume":"6","author":"Eddie","year":"2015","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.4927","article-title":"High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease","volume":"243","author":"Zhai","year":"2017","journal-title":"J. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Papp","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12645","article-title":"Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status","volume":"7","author":"Coscia","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/onc.2016.455","article-title":"PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer","volume":"36","author":"Modi","year":"2017","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1242\/dev.091785","article-title":"Pax genes: Regulators of lineage specification and progenitor cell maintenance","volume":"141","author":"Blake","year":"2014","journal-title":"Development"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/bies.950190905","article-title":"Pax genes and organogenesis","volume":"19","author":"Dahl","year":"1997","journal-title":"Bioessays"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1242\/dev.121.12.4057","article-title":"Pax-2 controls multiple steps of urogenital development","volume":"121","author":"Torres","year":"1995","journal-title":"Development"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e0191689-20","DOI":"10.1371\/journal.pone.0191689","article-title":"The histone demethylase LSD1 regulates inner ear progenitor differentiation through interactions with Pax2 and the NuRD repressor complex","volume":"13","author":"Patel","year":"2018","journal-title":"PLoS ONE"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.devcel.2007.09.004","article-title":"The BRCT-Domain Containing Protein PTIP Links PAX2 to a Histone H3, Lysine 4 Methyltransferase Complex","volume":"13","author":"Patel","year":"2007","journal-title":"Dev. Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAI.0b013e3181d712ef","article-title":"PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: A comprehensive immunohistochemical study","volume":"18","author":"Zhai","year":"2010","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1073\/pnas.0408840102","article-title":"Pax2 expression occurs in renal medullary epithelial cells in vivo and in cell culture, is osmoregulated, and promotes osmotic tolerance","volume":"102","author":"Cai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.onc.1205172","article-title":"Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth","volume":"21","author":"Silberstein","year":"2002","journal-title":"Oncogene"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1242\/dev.02614","article-title":"Pax2\/5\/8 proteins promote cell survival in C. elegans","volume":"133","author":"Park","year":"2006","journal-title":"Development"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ng0598-87","article-title":"Follicular cells of the thyroid gland require Pax8 gene function","volume":"19","author":"Mansouri","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/en.2006-1054","article-title":"Congenital Hypothyroid Female Pax8-Deficient Mice Are Infertile Despite Thyroid Hormone Replacement Therapy","volume":"148","author":"Mittag","year":"2007","journal-title":"Endocrinology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: A comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.humpath.2015.03.017","article-title":"PAX8 expression in ovarian surface epithelial cells","volume":"46","author":"Adler","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_53","first-page":"4230","article-title":"Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters","volume":"12","author":"Zannini","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/MCB.19.3.2051","article-title":"The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium\/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription","volume":"19","author":"Ohno","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ruiz-Llorente, S., Carrillo Santa de Pau, E., Sastre-Perona, A., Montero-Conde, C., G\u00f3mez-L\u00f3pez, G., Fagin, J.A., Valencia, A., Pisano, D.G., and Santisteban, P. (2012). Genome-wide analysis of Pax8 binding provides new insights into thyroid functions. BMC Genom., 13.","DOI":"10.1186\/1471-2164-13-147"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"(2011). Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609\u2013615.","DOI":"10.1038\/nature10166"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact","volume":"26","author":"Levanon","year":"2008","journal-title":"JCO"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1701-2163(15)30659-9","article-title":"The Fallopian Tube as the Origin of High Grade Serous Ovarian Cancer: Review of a Paradigm Shift","volume":"36","author":"Reade","year":"2014","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/path.4417","article-title":"The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium","volume":"234","author":"Ning","year":"2014","journal-title":"J. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"76881","DOI":"10.18632\/oncotarget.20173","article-title":"PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state","volume":"8","author":"Alwosaibai","year":"2017","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1158\/1940-6207.CAPR-15-0121-T","article-title":"Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer","volume":"8","author":"Tang","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nature04225","article-title":"Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis","volume":"438","author":"Wu","year":"2005","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1634\/stemcells.2007-0322","article-title":"Accumulation of Malignant Renal Stem Cells Is Associated with Epigenetic Changes in Normal Renal Progenitor Genes","volume":"26","author":"Metsuyanim","year":"2008","journal-title":"Stem Cells"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1073\/pnas.1109363108","article-title":"Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer","volume":"108","author":"Cheung","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Di Palma, T., Lucci, V., de Cristofaro, T., Filippone, M.G., and Zannini, M. (2014). A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-292"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ghannam-Shahbari, D., Jacob, E., Kakun, R.R., Wasserman, T., Korsensky, L., Sternfeld, O., Kagan, J., Bublik, D.R., Aviel-Ronen, S., and Levanon, K. (2018). PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma. Oncogene, 1\u201312.","DOI":"10.1038\/s41388-017-0040-z"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1038\/onc.2011.190","article-title":"PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein","volume":"30","author":"Li","year":"2011","journal-title":"Oncogene"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.289.5483.1357","article-title":"PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]","volume":"289","author":"Kroll","year":"2000","journal-title":"Science"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/carcin\/bgt357","article-title":"Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer","volume":"35","author":"Tanwar","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"32785","DOI":"10.18632\/oncotarget.9051","article-title":"Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium","volume":"7","author":"Rodgers","year":"2016","journal-title":"Oncotarget"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Elias, K.M., Emori, M.M., Westerling, T., Long, H., Budina-Kolomets, A., Li, F., MacDuffie, E., Davis, M.R., Holman, A., and Lawney, B. (2016). Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors. JCI Insight, 1.","DOI":"10.1172\/jci.insight.87988"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"108316","DOI":"10.18632\/oncotarget.22718","article-title":"The PAX8 cistrome in epithelial ovarian cancer","volume":"8","author":"Adler","year":"2017","journal-title":"Oncotarget"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.5858\/arpa.2012-0072-OA","article-title":"PAX2 and PAX8 Expression in Primary and Metastatic Renal Tumors: A Comprehensive Comparison","volume":"136","author":"Ozcan","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1073\/pnas.89.4.1179","article-title":"Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor","volume":"89","author":"Dressler","year":"1992","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0022-3468(94)90308-5","article-title":"Paired box gene expression in Wilms\u2019 tumor","volume":"29","author":"Tagge","year":"1994","journal-title":"J. Pediatr. Surg."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nature07483","article-title":"Regulation of ERBB2 by oestrogen receptor\u2013PAX2 determines response to tamoxifen","volume":"456","author":"Hurtado","year":"2008","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1158\/0008-5472.CAN-08-0058","article-title":"PAX8 Regulates Telomerase Reverse Transcriptase and Telomerase RNA Component in Glioma","volume":"68","author":"Chen","year":"2008","journal-title":"Cancer Res."},{"key":"ref_78","first-page":"235","article-title":"PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma","volume":"41","author":"Burger","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_79","first-page":"41929","article-title":"Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma","volume":"7","author":"Soriano","year":"2016","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acschembio.6b00782","article-title":"Inhibition of Pax2 Transcription Activation with a Small Molecule that Targets the DNA Binding Domain","volume":"12","author":"Grimley","year":"2017","journal-title":"ACS Chem. Biol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/10\/8\/262\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:17:21Z","timestamp":1760195841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/10\/8\/262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":80,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["cancers10080262"],"URL":"https:\/\/doi.org\/10.3390\/cancers10080262","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]}}}